Mt KARI-IN-4
Mt KARI-IN-4 (compound 5c) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a Ki value of 5.48 μM. Mt KARI-IN-4 has inhibitory activity against Mtb H37Rv (MIC = 0.78 μM) and low cytotoxicity (HEK IC50 > 72 μg/mL) [1].
Product Specifications
CAS Number
2413974-53-3
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mt-kari-in-4.html
Solubility
10 mM in DMSO
Smiles
O=[N+](C1=CC=C(O1)C2=NN=C(S2)NC(NC3=CC=C(C=C3)F)=S)[O-]
Molecular Formula
C13H8FN5O3S2
Molecular Weight
365.36
References & Citations
[1]Krishna VS, et al. Design and development of ((4-methoxyphenyl) carbamoyl) (5- (5-nitrothiophen-2-yl) -1,3,4-thiadiazol-2-yl) amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. Eur J Med Chem. 2020;193:112178.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY403324 100 µg
Viperin (RSAD2) (NM_080657) Human Over-expression Lysate
Sign In for Pricing
View Details 